Related Experiment Video

Updated: Oct 4, 2025

Antibody Binding Specificity for Kappa (Vκ) Light Chain-containing Human (IgM) Antibodies: Polysialic Acid (PSA) Attached to NCAM as a Case Study
11:10

Antibody Binding Specificity for Kappa (Vκ) Light Chain-containing Human (IgM) Antibodies: Polysialic Acid (PSA) Attached to NCAM as a Case Study

Published on: June 29, 2016

14.2K

IgA Monoclonal Gammopathy with Pseudohyperphosphatemia

Priti Rani1, Tarun Kumar1, Sushil Kumar1

  • 1Department of Biochemistry, All India Institute of Medical Sciences Patna, Patna, Bihar India.

Indian Journal of Clinical Biochemistry : IJCB
|February 7, 2022
PubMed
Summary

This study discusses monoclonal gammopathies (MGs), which involve abnormal immunoglobulin production. It highlights a specific case of IgA MG presenting with pseudohyperphosphatemia, a rare complication.

Keywords:
IgA monoclonal gammopathyMultiple myelomaPseudohyperphosphatemia

More Related Videos

Interphase Fluorescence in situ Hybridization of Bone Marrow Smears of Multiple Myeloma07:53

Interphase Fluorescence in situ Hybridization of Bone Marrow Smears of Multiple Myeloma

Published on: April 15, 2022

4.4K
An In Vitro Model for the Study of Cellular Pathophysiology in Globoid Cell Leukodystrophy07:45

An In Vitro Model for the Study of Cellular Pathophysiology in Globoid Cell Leukodystrophy

Published on: October 21, 2014

8.0K

Related Concept Videos

Hybridoma Technology01:31

Hybridoma Technology

Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
15.6K